  
<prompt> Trends in Intermittent Preventive Treatment during Pregnancy (IPTp)
 Percent of women age 15-49 with a live birth in past 2 years who received at least 1, 2, or 3 doses of SP/Fansidar 
 [["", "1+ dose", "2+ doses", "3+ doses"], ["EDSM 2006", 16, 11, 6], ["EDSM 2012-13", 56, 30, 12], ["EDSM 2015", 66, 44, 21], ["EDSM 2018", 74, 55, 28]] 
 <response> Nearly 3 in 4 (74%) pregnant women receive one dose of SP/Fansidar, 55% receive two doses, and 28% receive 3+ doses of SP/ Fansidar. The percent of women receiving SP/Fansidar has increased since 2006 when only 16% of women received at least one dose of SP/Fansidar.  